[Drugs in the pipeline].
Zlotos
Darius P
DP
Institut für Pharmazie und LMC, Universität Würzburg. zlotos@pzlc.uni-wuerzburg.de
D000818:Animals; D053961:Azabicyclo Compounds; D058785:GABA-A Receptor Agonists; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology* / Q000627:therapeutic use*; D051379:Mice; D018345:Mice, Knockout; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D044094:Receptors, Melatonin / Q000819:agonists; D018490:Serotonin Agents / Q000494:pharmacology / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000188:drug therapy*; D000077334:Zolpidem
D053961:Azabicyclo Compounds; D058785:GABA-A Receptor Agonists; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011725:Pyridines; D044094:Receptors, Melatonin; D018490:Serotonin Agents; C515050:zopiclone; D000077334:Zolpidem